Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$698
|
$662B |
11.9x |
28.7x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$176
|
$456B |
5.0x |
13.6x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$207
|
$429B |
7.3x |
15.9x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 258
|
$280B |
3.7x |
9.3x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£116
|
$267B |
4.6x |
13.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 100
|
$266B |
4.8x |
11.7x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 348
|
$253B |
5.3x |
10.7x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$84
|
$237B |
3.7x |
8.3x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$488
|
$213B |
4.9x |
19.5x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$293
|
$206B |
5.9x |
11.1x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$190B |
3.0x |
7.7x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$118
|
$166B |
5.8x |
12.0x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$209
|
$164B |
6.7x |
21.4x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$48
|
$135B |
2.8x |
9.7x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€84
|
$127B |
2.4x |
8.2x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 271
|
$96.1B |
6.1x |
18.0x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$95.7B |
2.2x |
6.6x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$390
|
$95.1B |
8.2x |
25.4x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4486
|
$75.6B |
2.4x |
9.4x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$152
|
$72.9B |
7.7x |
17.8x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€27
|
$68.9B |
1.3x |
6.1x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€112
|
$65.9B |
2.7x |
9.4x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6260
|
$62.8B |
7.7x |
15.3x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$457
|
$58.3B |
19.3x |
131.0x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$574
|
$56.1B |
4.0x |
11.3x |
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 64
|
$55.4B |
12.7x |
45.5x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$53.4B |
3.6x |
14.3x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 556
|
$52.9B |
5.9x |
20.4x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1028000
|
$52.7B |
13.8x |
32.1x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$638
|
$52.1B |
12.7x |
37.0x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$193
|
$46.2B |
2.9x |
12.4x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3782
|
$44.8B |
3.4x |
16.2x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€192
|
$43.6B |
5.6x |
19.9x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€46
|
$43.5B |
1.7x |
10.2x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1633
|
$42.0B |
6.8x |
23.8x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 134
|
$41.3B |
8.3x |
36.1x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 97
|
$37.6B |
6.4x |
16.1x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 199
|
$37.5B |
8.0x |
512.7x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 62
|
$35.8B |
2.1x |
7.4x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€554
|
$35.6B |
10.2x |
56.0x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$118
|
$35.6B |
5.3x |
18.2x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 48
|
$30.1B |
2.7x |
12.9x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1311
|
$29.1B |
7.4x |
23.4x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 172900
|
$29.1B |
10.1x |
31.1x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$270
|
$28.4B |
2.1x |
12.2x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 7924
|
$26.8B |
1.7x |
7.3x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$26.3B |
1.9x |
6.1x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$179
|
$26.1B |
2.5x |
12.4x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$127
|
$25.6B |
59.4x |
-26.6x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 37
|
$24.8B |
13.5x |
36.6x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1685
|
$24.7B |
1.9x |
9.3x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$136
|
$23.8B |
2.5x |
7.3x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 11
|
$23.1B |
2.3x |
6.6x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$323
|
$23.0B |
9.5x |
40.9x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€177
|
$22.7B |
6.7x |
22.8x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$36
|
$22.0B |
7.5x |
8.1x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 102
|
$21.5B |
14.2x |
286.6x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$161
|
$21.3B |
10.9x |
-86.1x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$19.2B |
N/A |
-63.5x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 172
|
$19.2B |
45.9x |
7369.8x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€11
|
$18.5B |
2.1x |
8.7x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$289
|
$18.4B |
6.0x |
16.6x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6165
|
$18.3B |
16.2x |
50.4x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€68
|
$17.9B |
2.1x |
9.7x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$101
|
$17.4B |
4.0x |
15.2x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€126
|
$17.3B |
3.6x |
15.2x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$17.3B |
4.0x |
16.4x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 309
|
$17.1B |
35.5x |
113.3x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$179
|
$17.0B |
2.1x |
10.3x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 201
|
$16.9B |
10.8x |
31.5x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 439500
|
$16.6B |
118.2x |
226.6x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 31
|
$15.2B |
5.4x |
15.8x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 11
|
$14.8B |
3.6x |
14.5x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€51
|
$14.7B |
5.0x |
13.3x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3652
|
$14.4B |
10.4x |
31.9x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$85
|
$14.2B |
3.1x |
14.7x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1564
|
$13.3B |
4.1x |
16.3x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$463
|
$13.1B |
5.7x |
25.9x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 447
|
$12.9B |
46.5x |
-285.9x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$90
|
$12.8B |
4.5x |
15.0x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 27
|
$12.7B |
2.2x |
15.4x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$12.7B |
4.8x |
19.8x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$12.5B |
2.7x |
14.1x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2470
|
$12.4B |
8.2x |
32.3x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€170
|
$12.4B |
N/A |
N/A |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.3B |
2.2x |
15.7x |
Sonic Healthcare
|
Australia |
Laboratory Services,
Medical Imaging & Diagnostics
|
AUD 28
|
$12.0B |
1.9x |
10.2x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1264
|
$11.8B |
3.1x |
12.0x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1508
|
$11.7B |
3.3x |
9.2x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2640
|
$11.5B |
3.7x |
9.3x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€69
|
$11.5B |
5.9x |
18.6x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 274
|
$11.1B |
3.9x |
10.6x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$314
|
$11.1B |
3.6x |
6.7x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$49
|
$11.0B |
5.4x |
14.7x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$113
|
$10.9B |
4.1x |
-7.7x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$118
|
$10.9B |
2.6x |
9.0x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 987
|
$10.8B |
4.0x |
13.7x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 44
|
$10.6B |
1.7x |
13.6x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1969
|
$10.6B |
3.9x |
16.2x |